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Neuropathic pain drives anxiety behavior in mice,
results consistent with anxiety levels in diabetic
neuropathy patients
Christine B. Sieberga,b,c, Caitlin Tarasd, Aya Gomaad, Chelsea Nickersond, Cindy Wongb,c, Catherine Wardd,
Georgios Baskozose, David L.H. Bennette, Juan D. Ramireze, Andreas C. Themistocleouse,f, Andrew S.C. Riceg,
Pallai R. Shilloh, Solomon Tesfayeh, Robert R. Edwardsi, Nick A. Andrewsd, Charles Berdea, Michael Costigana,d,*
Abstract
Background: Epidemiological studies in patients with neuropathic pain demonstrate a strong association with psychiatric conditions
such as anxiety; however, the precipitating pathology between these symptoms remains unclear. To investigate this, we studied the
effects of lifelong stress on levels of neuropathic pain–like behavior and conversely, the effects of chronic neuropathic injury on anxiety-
like status in male and female mice. In addition, we assayed this link in painful and painless diabetic peripheral neuropathy patients.
Methods:Male and femalemicewere subject to ongoing life-stress or control living conditions. Baseline sensitivity and anxiety tests
were measured followed by spared nerve injury (SNI) to the sciatic nerve. Subsequent sensory testing occurred until 3 weeks after
SNI followed by anxiety tests between 4 and 6 weeks after SNI.
Results: Levels of tactile or cold allodynia did not differ between adult mice subject to lifelong chronic stress, relative to nonstressed
controls, for at least 3 weeks after SNI. By contrast, longer-term neuropathic mice of both sexes displayed pronounced anxiety-like
behavior, regardless of exposure to stress. If sex differences were present, females usually exhibited more pronounced anxiety-like
behavior. These ongoing anxiety behaviors were corroborated with plasma corticosterone levels in distinct animal groups. In
addition, data from patients with painful and nonpainful diabetic neuropathy showed a clear relationship between ongoing pain and
anxiety, with females generally more affected than males.
Discussion: Taken together, these data demonstrate a strong link between chronic neuropathic pain and chronic anxiety, with the
driver of this comorbidity being neuropathic pain as opposed to on-going stress.
Keywords: Pain, Anxiety, Stress, Spared nerve injury, Neuropathy, Sex differences
1. Introduction
Studies show a strong comorbidity of chronic neuropathic pain
with anxiety disorders and depression.21,33 These associations
are also present in young patients,18,37 which is concerning
because of the potential impact on neural development during
critical stages of development, with long-term consequences in
adulthood.5,41 The strong links between ongoing pain and
chronic anxiety are well known, but it remains difficult to separate
cause and effect in these 2 highly correlated diseases.12,34 How
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biological sex interacts with these disorders is also not well
understood, although both chronic anxiety and pain conditions
are more prevalent in females.20 In addition to determining the
etiology of chronic pain and anxiety, understanding their relation-
ship may help target treatments more effectively, for instance, in
determining which patients with chronic pain are likely to benefit
from drugs with analgesic and anxiolytic properties, for example,
gabapentin or duloxetine.13
As there is a need to develop amodel that allows for insight into
the affective component of chronic pain, the aim of this study,
which includes preclinical and clinical data, was to characterize




All animal procedures were approved by the Boston Children’s
Hospital Animal Care and Use Committee, under animal protocol
numbers 15-04-2928R and 16-01-3080R. All experiments were
conducted in a blinded fashion in a quiet room from 09:00 to 18:
00.Male and female adult C57BL/6mice (delivered 6–7weeks for
use at 9 weeks) were obtained from Charles River Labs (CRL).
Time-mated female mice were delivered 1 week before birth from
CRL. Special care was taken to not disturb the mice (eg, cage
changing) on test days, to avoid transient stress confounds. Mice
were housed with their littermates (up to 5 mice per cage)
in OptiMICE cages with food and water ad libitum (temperature
22 6 1˚C, 50% relative humidity, lights on from 07:00 to 19:00).
Each behavioral test was performed on 2 independent cohorts
of male and female mice, the data checked for consistency then
merged.
2.2. Treatment timeline
Figure 1 shows the timeline formice that were exposed to ongoing
life stress or left alone, before spared nerve injury (SNI)-induced
neuropathic pain. Baseline sensitivity tests were measured before
SNI injury (in 7–8-week-old mice) and at defined points following it.
With the exception of 2 weeks in early life, chronically stressed
animals were continuously subject to maternal separation (MS) or
chronic mild stress (CMS) throughout the experiment. Plasma
corticosterone levels were measured in 3 distinct groups of mice,
naive (nonstressed); mice with SNI; or mice that underwent MS
followed by CMS. Each was age matched to the SNI results and
taken at 4 to 5 weeks after nerve injury.
2.3. Chronic stressors
2.3.1. Maternal separation
From P5, pups were separated from their mother’s home cage
and placed on a warm surface (30˚C) for 2 hours between 11:00
and 13:00 each day and then returned to their home cage dams.
This procedure was repeated daily until P19. At P21, the mice
were separated by sex and housedwith their littermates up to n5
5 per cage. After this, the mice were left for 1 week until P29
(4 weeks).
2.3.2. Chronic mild stress
Previously, maternally separated mice were subject to CMS from
4 weeks of age. One of 8 stressors was randomly performed on
each cage of animals every day for 6 of the 7 days in the week
based on previous studies.27,44 The stressors were: (1) cage
shake (horizontal shaking, 5 minutes); (2) cold swim (5 minutes
per mouse); (3) cage tilt (45˚ for 8 hours); (4) space reduction (50%
Figure 1. Experimental timeline for male and female mice differentially subjected to ongoing life stress (A) or control unstressed mice (B) before SNI. Baseline
sensitivity tests were measured before SNI and anxiety tests were performed before and after SNI within the time frames shown. A separate group of animals were
used for plasma blood draws and these assaysweremeasured between 4 and 5weeks after SNI andwithin the same time frame for control and ongoing life-stress
animals. SNI, spared nerve injury.
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cage space for 8 hours); (5) moist bedding (400 mL of water
tipped onto bedding and mice left for 8 hours); (6) overnight food
deprivation (16 hours); (7) daytime water deprivation (8 hours);
and (8) overnight illumination (lights on from 19:00 to 07:00 in
addition to the normal day light period). Once the list of 8
interventions was complete, a new random run of the 8 different
interventions was performed and this procedure was repeated
until the end of the experiment.
2.4. Peripheral nerve injury
Mice were anesthetized with isoflurane (2%–4%) at 9 weeks and
SNI surgery performed; the tibial and common peroneal
branches of the sciatic nerve were tightly ligated with a silk suture
and transected distally, whereas the sural nerve was left intact.4,8
2.5. Sensitivity assays
2.5.1. Measures of mechanical and cold allodynia
The behavioral time course of tactile and cold sensitivity before
and after SNI in C57BL/6 mice was measured as in Refs. 4,8.
Mice were tested twice at baseline and then 7, 14, and 21 days
after SNI. For the CMS cohort, the mice were not subject to the
CMS procedure on the day of testing. Mechanical allodynia was
measured using von Frey filaments (Touch-Test Sensory
Evaluators; North Coast Medical, Inc, Gilroy, CA) ranging from
0.02, 0.04, 0.07, 0.16, 0.4, 0.6, 1, and 2 g, respectively. Each
filament was tested 10 times in increasing order starting with the
filament producing the lowest force. Von Frey filaments were
applied at least 3 seconds after the mice had returned to their
initial resting state. For the baseline mechanical sensitivity test, all
filaments were applied and the number of withdrawals was
recorded. For tactile allodynia, the minimal force filament for
which animals presented either a brisk paw withdrawal and/or an
escape attempt in response to at least 5 of the 10 stimulations
determined the mechanical response threshold. Cold allodynia
was assayed by applying a 5 mL drop of acetone to the hind paw,
ipsilateral to SNI injury, and measuring the amount of time the
animal spent flinching/licking/biting the paw in seconds.
2.6. Anxiety assays
2.6.1. Elevated plus maze
The elevated plus maze consisted of 2 open and 2 closed arms
each opposite its counterpart, extended from a central platform
to create a plus shape elevated 50cm above the floor. Mice were
placed on the center platform of the maze, facing a closed arm,
and allowed to explore the apparatus for 5 minutes. The percent
of time spent in open arms was used as a surrogate measure of
anxiety-like states.30 Distance travelled in the closed arms was
considered as a measure of locomotor activity.
2.6.2. Holeboard
The apparatus consisted of a square arena surrounded by a wall.
Sunken into the arena floor were 9 holes equally spaced in 3 rows.
Activity (horizontal movement and investigation of the holes) was
detected by infrared beams and recorded by a computer. The
test duration was 15 minutes and was initiated by placing
a mouse into the periphery of the arena. Total distance traveled in
the periphery (ambulation), total time spent in the center
(nonanxious behavior), and total number of nose pokes into the
holes (exploratory behavior) were assessed.
2.6.3. Light dark box
The apparatus consisted of a 2-compartment chamber con-
nected by a small aperture that allowed free access to both sides.
The test began by placing a mouse in the dark compartment and
recording behavior; time spent in the lit compartment (non-
anxious behavior) and distance traveled in the light zone
(ambulation) were recorded.
2.7. Determination of plasma corticosterone concentration
Plasma corticosterone levelsweremeasured in 3 distinct groups of
mice, naive (nonstressed); mice with SNI; or mice that underwent
MS followedbyCMS. Eachof thesegroupswas further divided into
mice that underwent acute restraint stress or remained unstressed
in the home cage before blood collection. Restraint stress
consisted of mice inserted into 50mL conical polypropylene tubes
for 5 minutes. The tube had holes placed along its length and the
conical face removed to aid breathing. After restraint, the mice
were returned to their home cage for 20 minutes and then
euthanized with carbon dioxide inhalation before cardiac puncture
to collect blood samples, stored in 3mLEDTA tubes. Unrestrained
mice were left in their home cage undisturbed before blood
collection. All mice were euthanized in a room separated from that
of housing before sample collection. All samples were collected
between 11:00 and 13:00. Plasma was prepared from the blood
samples and stored at280˚C until required. CORT was quantified
by ELISA (#ADI-900-097; Enzo Life Sciences, Farmingdale, NY)
according to the manufacturer’s instructions.
2.8. Neuropathic patients
Data are presented on 176 adult patients with diabetes mellitus
who participated in the Pain in Neuropathy Study (PiNS), a cross-
sectional observational multicenter study in the United Kingdom
designed to determine the somatosensory phenotype of painful
and painless diabetic peripheral neuropathy. The total cohort
consists of 191 participants; however, 15 did not complete the
anxiety questionnaire. Information on study methodology and
sample has been published.39
Participants underwent a neurological examination, quantita-
tive sensory testing, nerve conduction studies, and skin biopsy for
intraepidermal nerve fiber density assessment. Toronto Clinical
Scoring System (TCSS) was used as a screening tool for diabetic
peripheral neuropathy and correlates with diabetic neuropathy
severity.6 Participants also completed a series of questionnaires
assessing the presence of pain, pain intensity, pain distribution,
and psychological and functional impact of pain. The Depression
Anxiety Positive Outlook (DAPOS) measure31was used to assess
anxiety; a 7-day pain diary to assess ongoing neuropathic pain
intensity39; TCSS as a measure of diabetic neuropathy severity;
HbA1c (glycated haemoglobin-A1c concentration as a measure
of average plasma glucose concentration over the preceding 120
days); age; and body mass index (BMI).
Sample size was determined according to the warm detection
threshold for patients with diabetes (Shun et al., 2004), which
revealed that a minimum sample size of 34 was required per
group for a power of.0.8, SPSSStatistics Version 22 (IBM). Data
were tested for normality with the D’Agostino-Pearson normality
test and by visual inspection. Data were not normally distributed
and are reported as median with interquartile range. Data were
compared across multiple groups with the Kruskal–Wallis test
(the Dunn post hoc test). In the case of comparisons between 2
groups only, the nonparametric Wilcoxon rank-sum test was
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used. Spearman correlation analyses were performed to explore
associations between DAPOS anxiety and pain intensity. A
multivariate analysis was performed to control for potential
confounding factors. Ranked nonparametric multivariate analysis
of variance (ANOVA) with the Wilk’s Lambda statistic and
multivariate principal component analysis were performed. All
values were normalized and scaled before analysis. Statistical
significance set at P , 0.05.
3. Results
3.1. Tactile and cold allodynia in stressed and
unstressed mice
To measure tactile sensitivity, we used von Frey filaments (Fig.
2A). Baseline means were averaged. The 2 (Sex)3 2 (Group)3
4 (Time) ANOVA revealed a significant main effect of Time
[F(3,73) 5 86.2, P , 0.001], and Group 3 Time [F(3,73) 5 2.6,
P 5 0.05] as well as Sex 3 Time [F(3,73) 5 2.9, P , 0.05]
interactions. Follow-up univariate analyses indicated that naive
(unstressed) female mice showed significantly lower values
(greater tactile sensitivity) compared with the other 3 groups at
baseline. No group differences were evident thereafter. Collec-
tively, after SNI, all mice developed strong levels of tactile
allodynia by 7 days after injury and this was maintained until at
least 21 days.
Similarly, cold allodynia (Fig. 2B) developed fully by 7 days after
SNI and was sustained for 21 days. The 2 (Sex) 3 2 (Group) 3 4
(Time) ANOVA revealed a significant main effect of Time [F(3,73)
5 125.5, P, 0.001], and a significant Group3 Time interaction
[F(3,73) 5 4.7, P , 0.01], although follow-up univariate analyses
indicated no significant differences from baseline to day 21.
Overall, the effect of SNI on tactile and cold hypersensitivity in
mice was independent of sex or previous chronic stress.
3.2. Long-term neuropathic injury induces anxiety-like
behavior in mice (elevated plus maze)
The 2 (Sex: M vs F)3 2 (Group: Control vs Stress)3 2 (Time: N vs
SNI) ANOVA (Fig. 3) revealed a significant main effect of Time
(SNI) [F(1,69)5 65.4, P, 0.001] and a significant Group (Stress)
3 Time (SNI) interaction [F(1,69)5 9.8,P, 0.005], indicating that
SNI induces increased anxiety behavior. The chronically stressed
groups spent less time on the open arms before SNI (P , 0.05),
and control female mice spent significantly less time in the open
arms after SNI (P , 0.05). It is important to note that adding
distance traveled (not shown) as a covariate to the ANOVA did not
change this pattern of results, suggesting that the observed
effects are not a consequence of a general loss of activity levels
after SNI.
3.3. Long-term neuropathic injury induces anxiety-like
behavior in mice (holeboard)
In the holeboard arena (Fig. 4), the 2 (Sex) 3 2 (Group) 3 2
(Time) ANOVA on the index of time spent in the holeboard
center (Fig. 4A) revealed significant main effects of Time (SNI) [F
(1,67) 5 68.4, P , 0.001], Group (Stress) [F(1,67) 5 5.4, P ,
0.05], a significant Group 3 Time interaction [F(1,69) 5 44.6,
P , 0.001], and a significant Group 3 Sex 3 Time interaction
[F(1,67) 5 9.3, P , 0.005]. Follow-up analyses indicated that
the chronically stressed groups spent less time in the center
than the unstressed groups (P , 0.05), and sex differences
were only evident in the chronically stressed group (with
stressed females demonstrating less center time than stressed
males, P, 0.05). After SNI, only the unstressed groups showed
significant reductions in time spent in the holeboard center;
indeed, chronically stressed females had higher scores than
unstressed females after SNI (P5 0.01). These findings suggest
that chronic stress amplifies anxiety behaviors, particularly in
females, but that chronic stress also seems to buffer the
anxiety-promoting impact of SNI. Adding distance traveled in
the periphery as a covariate did not change the pattern of group
differences (not shown).
The 2 (Sex) 3 2 (Group) 3 2 (Time) ANOVA for number of
holeboard nose pokes (exploratory behavior) (Fig. 4B) revealed
a significant main effect of Time (SNI) [F(1,67)5 13.9, P, 0.001],
a significant main effect of Sex [F(1,67) 5 7.5, P , 0.005], and a
significant Group3 Time interaction [F(1,69)5 16.5, P, 0.001].
After SNI, nose pokes decreased in all groups, with no significant
sex or group differences. Adding distance traveled as a covariate
did not change the pattern of results.32
3.4. Long-term neuropathic injury induces anxiety-like
behavior in mice (light dark box test)
The 2 (Sex)3 2 (Time) ANOVA for time spent in the light during the
light dark box assay (Fig. 5) revealed a significant main effect of
Time (SNI) [F(1,33)5 57.7, P, 0.001], with no main effect of Sex
and no significant interaction (Fig. 5). Both male and female mice
exhibited significant reductions in time spent in the light after SNI.
These effects were not attributable to reductions in locomotion;
adding distance as a covariate did not change the pattern of
results.
3.5. Plasma corticosterone levels increase due to spared
nerve injury and chronic stress
Given the behavioral findings that long-term SNI drives anxiety-
like behavior, we compared plasma corticosterone levels in mice
at 4 to 5 weeks after SNI to naive unstressed controls and
chronically stressed mice. We also assayed corticosterone levels
in restrained and unrestrained mice (see Methods), with un-
restrained levels of corticosterone being a marker of baseline
stress levels. Over time, chronically increased plasma cortico-
sterone leads to the desensitization of the glucocorticoid receptor
system, resulting in larger levels of corticosterone produced in
reaction to a novel acute stress.24
As expected, unrestrained animals produced significantly less
corticosterone than the restrained animals (P, 0.001) across all
subgroups. In the unrestrained group (Fig. 6A), the naive and
chronic stress groups differ at P , 0.05 and the naive and SNI
groups differ at P, 0.01, with the chronic stress and SNI groups
differing at P , 0.05, with no sex differences. Long-term SNI is
therefore a stronger inducer of basal corticosterone levels than
lifelong chronic stress. In the restrained group (Fig. 6B), the naive
vs the chronic stress comparison is significant at P , 0.005 with
the naive vs SNI significant at P, 0.001, suggesting that chronic
stress and SNI are each capable of significantly increasing
corticosterone levels. Control males and post-SNI males had
higher corticosterone levels than control and post-SNI females,
respectively (P , 0.01).
Overall, regardless of restraint or nonrestraint status, long-term
SNI and lifelong chronic stress result in greater levels of plasma
corticosterone production than that seen in naive animals,
consistent with these treatments being at least equally effective
stressors.
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3.6. Anxiety scores in patients with painful vs nonpainful
diabetic neuropathy
In the PiNS study cohort, anxiety scores increased successively
as levels of neuropathic pain increased, irrespective of sex
(Fig. 7A). Anxiety scores were higher for participants with painful
neuropathy compared with same-sex study participants with
painless neuropathy (Fig. 7B). Female participants with painful
neuropathy reported significantly higher anxiety scores com-
pared with male participants with painful neuropathy (P , 0.05),
with no sex differences for painless neuropathy (Fig. 7B).
Figure 2.Male and female C57BL/6 chronic stress or nonstressedmice were tested for tactile (A) or cold (B) sensitivity pre- (BL2 and BL3 2 independent baseline
values) and post-SNI (each group contained n 5 19 to 20 mice). (A) Repeated-measures ANOVA results for tactile allodynia in male and female control and
stressed mice demonstrated a main effect for time (P, 0.001) indicating a significant effects of SNI over the time course for all mice, and a significant interaction
effect (P , 0.05). Post-hoc Tukey tests follow-up analysis revealed a significant difference between naive control females and the other groups before surgery.
After SNI, all mice, stressed and nonstressed of both sexes, developed strong levels of tactile and cold allodynia by 7 days after injury and this wasmaintained until
at least 21 days. (B) Repeated-measures ANOVA results for cold allodynia in each group demonstrated a main effect for time (P, 0.001) indicating a significant
effects of SNI over the time course for all mice. Error SEM. ANOVA, analysis of variance; SNI, spared nerve injury.
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Scatter plots of DAPOS Anxiety and pain intensity showed
a significant correlation r 5 0.37, P , 0.01 (Fig. 7C), which was
strongest for female study participants r5 0.45,P, 0.01 (Fig. 7E).
A multivariate analysis was performed to control for potential
confounding factors (Fig. 8 and Supplemental Fig. 1, available
online at http://links.lww.com/PR9/A18). Multivariate principal
component analysis included: Sex, age, BMI, HbA1c, intra-
epidermal nerve fiber density, DAPOS, anxiety, TCSS, and
neuropathic pain intensity. Variables were normalized and used
to construct principal components. Multivariate analysis effectively
separated participants diagnosed with painful and painless
neuropathy. Painful neuropathy participants are better associated
with principal component 1 (PC1) (estimate5 0.79, P5 3.8e219)
than PC2 (estimate 5 0.41, P 5 1.87e207), see centroids of
patient groups and color coding of individual pain patients (Fig. 8A).
PC1 is strongly correlated with neuropathic pain intensity (cor 5
0.74, P 5 9.54e235), anxiety (cor 5 0.64, P 5 9.36e224), and
HbA1c (cor 5 0.57, P value 5 3.38e218). Furthermore, BMI
showed amodest correlation (cor5 0.33, P5 1.61e206) and age
was anticorrelated (cor5 20.57, P 5 6.71e218). PC2 is strongly
correlated with TCSS (cor5 0.82, P5 5.13e249) and age (cor5
0.59, P5 5.61e220) (Fig. 8A). Female participants are associated
with PC1 (estimate 5 0.25, P 5 1.42e202), whereas male
participants are associatedwith PC2 (estimate5 0.30,P53.43e2
04), although both associations are relatively modest (Fig. 8B). The
nonparametricWilcoxon rank-sum test showed that anxiety scores
(P 5 0.01), TCSS (P 5 0.0079), BMI (P 5 9.9e205), age (P 5
0.014), and daily pain intensity (P 5 0.043) were significantly
different between the sexes (Supplemental Fig. 1, available onlineat
http://links.lww.com/PR9/A18).
In summary, multivariate analysis found significant relation-
ships between anxiety scores and multiple variables including
painful neuropathy diagnosis, neuropathic pain intensity, plasma
glucose concentration, and BMI. Study participants with more
severe neuropathic pain reported greater levels of anxiety.
Figure 3. Time spent on the open arms of the elevated plusmaze as ameasure
of anxious-like behavior in male and female C57BL/6 naive, chronic stress,
nonstressed post-SNI and chronic stress post-SNI mice (each group
contained n 5 16–20 mice). Repeated-measures ANOVA results a main
effect of SNI (P , 0.001), a significant Stress vs SNI interaction (P , 0.005),
and follow-up Tukey test analyses indicate that the control stress groups spent
more time on the open arms control SNI groups (P, 0.05, in blue). Error SEM.
ANOVA, analysis of variance; SNI, spared nerve injury.
Figure 4. (A) Time spent the center of the holeboard arena as a measure of
anxious-like behavior in male and female C57BL/6 naive, chronic stress,
nonstressed post-SNI, and chronic stress post-SNI mice (each group contained
n 5 16–20 mice). Repeated-measures ANOVA results demonstrate a main
effect of SNI (P , 0.001) with a significant Stress vs SNI interaction (P , 0.05).
Follow-up analyses revealed that chronic stress mice spent significantly more
time in the center of the holeboard than post-SNI controlmice (P, 0.05, in blue).
Male chronically stressed mice spent significantly more time in the center than
their female counterparts (P , 0.05, in blue). Leading to a significant Sex 3
Stress 3 SNI interaction (P , 0.005, not shown on graph). (B) The number of
nose pokes into all the holes in the holeboard as a measure of exploratory
behavior. Repeated-measures ANOVA results demonstrate a main effect of SNI
(P , 0.001), main effect of Stress (P , 0.001) and a main effect of Sex (P ,
0.005, not shown on graph). Post-hoc analysis revealed that stressed female
mice engage in fewer holeboard nose pokes than males (P, 0.05, in blue) and
stressed mice are more exploratory than control SNI mice (P , 0.05, in blue).
Error SEM. ANOVA, analysis of variance; SNI, spared nerve injury.
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Women reported higher anxiety scores than males, although
levels of anxiety for both sexes with painful neuropathy were
significantly increased.
4. Discussion
Preclinical and clinical data confirm the substantial comorbidity
between chronic pain and affective distress;16,33,37 however, it is
less clear whether psychiatric comorbidities pre-date or result
from the onset of neuropathic pain. Current literature on this issue
are conflicted; although some studies indicate that early-life
stress exacerbates allodynia,7,26,28 others suggest that chronic
stress reduces levels of neuropathic mechanical allodynia.14,36
Our data suggest the underlying mechanisms of nerve
injury–induced tactile or cold allodynia are not modulated by
ongoing stress or sex, at least until 3 weeks after SNI in C57BL/6
mice.
Next, we assayed longer-term neuropathic mice (4–6 weeks
after SNI) using 3 well-characterized tests of neophobia. Again,
published data in this area are contradictory, with some showing
no association between nerve injury and anxiety behavior,17,40
whereas others show that neuropathic injury increases anxiety-
like behavior.9,23,25,38,45 Interestingly, our findings combined with
these other studies suggest a time sensitivity to these events.
Within the first few weeks after nerve injury, affective state was
relatively unaffected,17,40 but with neuropathic pain for more than
4 weeks after injury, anxiety-like behavior becomes appar-
ent.9,23,25,38,45 Defining ongoing long-term pain hypersensitivity
as the precipitant of clinical anxiety is an essential improvement in
our understanding of these 2 strongly linked conditions.
We also assayed the effects of sex, and where differences were
present, females were usually more susceptible to anxiety-like
Figure 5. Time spent in the light area of the light dark box as a measure of
anxious-like behavior in male and female C57BL/6 naive, nonstressed post-
SNI mice (each group contained n 5 16–20 mice). Mice of both sexes spent
significantly less time in the light arena after SNI (P , 0.001). Error SEM. SNI,
spared nerve injury.
Figure 6. Plasma corticosterone levels in unrestrained (A) and restrained
(B) male and female, control and stressed mice before and after SNI (each
group contained n 5 6–10 mice). (A) Within the unrestrained group,
repeated-measures ANOVA demonstrates a main effect for SNI (P, 0.01)
and for Stress (P , 0.05) with a significant difference between these
groups (P , 0.05). (B) Within the restrained group, repeated-measures
ANOVA demonstrates a main effect of SNI (P , 0.001) and for stress (P ,
0.005). Post-hoc analysis demonstrates that a significant effect of sex (P,
0.01) was revealed in naive and post-SNI mice, with higher levels of plasma
corticosterone in males relative to females. Error SEM. ANOVA, analysis of
variance; SNI, spared nerve injury.
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behaviors, despite similar levels of ongoing tactile and cold
hypersensitivities after SNI. A limitation here is that the stage of
the estrous cycle was not assessed in the female animals and
further work is needed to look at the different stages of the cycle in
the context of the pain and anxiety relationshipswe have uncovered
to determine the impact on the estrous cycle.
We also found that chronic lifelong stress, as well as long-term
SNI, increased tonic levels of plasma corticosterone in both
sexes. Increased regulation of corticosterone was still evident
after acute stress relative to naive mice, suggesting chronic
desensitization of corticosterone signaling by lifelong stress or
long-term SNI. Other published data also demonstrate increased
plasma corticosterone levels after nerve injury,3,22,42 or chronic
stress,10,19,35 as well as evidence for upregulation of corticoste-
rone signaling pathways after peripheral nerve injury.42,43Overall,
our data demonstrate that long-term SNI and chronic stress are
about equivalent in increasing plasma corticosterone levels,
suggesting similar levels of signaling through this endogenous
stress system for each condition.
Although chronic neuropathic pain and ongoing anxiety have
been linked, the fact that neuropathic injury precipitates anxiety-
like behavior has not been defined and the timing of its
appearance has not been clear. Our data also offer mechanistic
evidence as to why many anxiolytic drugs, such as gabapentin/
pregabalin, tricyclic antidepressants, and serotonin–norepinephrine
reuptake inhibitors are also effective neuropathic pain medi-
cations.11,13 Such drugs can increase norepinephrine in the spinal
cord, which alleviates pain29; however given our data, it is possible
that the reduction of high anxiety-like levels alone also contribute to
the efficacy of these drugs. It would be of future interest to test how
well anxiolytics with an antineuropathic pain component reduce
comorbid anxiety-like behavior levels as well as pain-like behavior
scores and in addition analyze how anxiolytic drugs without
a recognized antineuropathic effect would perform in the same
tests. As in rodents, it has been difficult to establish in humans
whether psychological distress is a precursor to34 or consequence
of12 living with chronic pain, so comparing those patients with
painful vs painlessdiabetic neuropathy offers somepotential insight.
Our patient data are consistent with the animal findings, in that
anxiety scores were higher for those with painful neuropathy, and
women reportedhigher levels of anxiety and a stronger pain–anxiety
relationship. Our findings align with other diabetic neuropathy
studies where greater pain intensity relates to more anxiety and
depression.2,15Here, we demonstrate a strong correlation between
increased anxiety levels in either mice subject to SNI injury or
patients suffering painful diabetic neuropathy, one may postulate
Figure 7. (A) Scatter plot and median (interquartile range) of DAPOS Anxiety scores for study participants with painless and painful diabetic neuropathy. Study
participants with painful diabetic neuropathy were subdivided into thosewithmild andmoderate/severe neuropathic pain based on themean pain scores obtained
from the 7-day pain intensity pain diary (0–3.9mild neuropathic pain, and 4–10moderate/severe neuropathic pain). (B) Scatter plot andmedian (interquartile range)
of DAPOS Anxiety scores for male and female study participants with painless and painful diabetic neuropathy. The Kruskal–Wallis and the Dunn multiple
comparison test: *P, 0.05, **P, 0.01. (C–E) Scatter plot of DAPOS Anxiety scores against 7-day pain intensity diary mean in all study participants with diabetic
neuropathy (C). Male study participants with diabetic neuropathy (D) and female study participants with diabetic neuropathy (E). DAPOS Anxiety scores were
correlated with 7-day pain intensity mean for all study participants with female study participants showing a greater correlation than male study participants.
DAPOS, Depression Anxiety Positive Outlook.
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Figure 8. Multivariate PCA of patients with painful and painless neuropathy. Variables: age; body mass index (BMI); glycated haemoglobin-A1c concentration
(HbA1c); intraepidermal nerve fiber density (IENFD); DAPOS Anxiety score (Anxiety); extent of peripheral nerve damage (TCSS), and Pain Diary 7-day mean
(chronic pain) were normalized and used to construct principal components. (A) Painful/painless neuropathy patient diagnosis was not used to construct the PC
plots but was tested for differences in principal components using 1-way ANOVA. PC1 was strongly characterized painful neuropathy patients (estimate: 0.79,
P value: 3.89e219) with PC2 also significantly characterized by patients with painful neuropathy (estimate: 0.42, P value: 1.87e207). Individuals factor map based
on the 2 first principal components. Minor dots represent individual patients, diagnosed with painful (red) or painless neuropathy (green). High anxiety patients
(DAPOS Anxiety score $ third quantile threshold) are indicated by dark center point. Large dots and ellipses represent the euclidean centroids of painful and
painless neuropathy patient groups. PC1 is characterized and correlated with chronic pain, anxiety, HbA1c concentration and BMI and anticorrelated with age. Of
which, chronic pain (correlation coef.5 0.74,P value5 9.54e235) and anxiety (correlation coef.5 0.64,P value5 9.36e224) are themost important factors. PC2
is characterized and correlated with TCSS, age, and chronic pain and anticorrelated with BMI and IENFD. Of which, TCSS (correlation coef. 5 0.82, P value 5
5.13e249) and age (correlation coef.5 0.60, P value5 5.61e220) are the most important factors. Only variables with significant correlations are plotted (P value
,0.05), arrow length is proportional to Pearson correlation coefficient. (B) Patient sex was not used to construct the principal components’ PC plots but was tested
for differences in principal components using 1-way ANOVA. PC1 was characterized slightly by females (estimate: 0.25, P value: 1.42e202). PC2 was modestly
characterized by males (estimate: 0.30, P-value: 3.43e204). Minor dots represent individual patient’s sex with male (blue) and female (purple), center points
designate high anxiety patients. Large dots and ellipses represent the euclidean centroids of male and female patient groups. ANOVA, analysis of variance;
DAPOS, Depression Anxiety Positive Outlook; PCA, principal component analysis; TCSS, Toronto Clinical Scoring System.
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that these conditions are too dissimilar to compare; however, we
would suggest that the remarkable similarity of risk profiles
demonstrated in these data, including a female predominance
speaks to an essential mechanism through mammalian biology,
one that basically connects longer-term ongoing painful sensory
inputwith central changes that precipitatemarked anxiety inmice or
patients. These correlations hold true, despite the initial source of
chronic painful sensory input, be it metabolic disease to the
peripheral nervous system or frank experimental nerve injury and of
course across species.
Anxiety-like behaviors in mice subject to long-term SNI were
comparable with those in mice subject to both long-term SNI and
lifelong stress. Translated to patients, these results would
suggest that neuropathic pain and anxiety do not combine to
produce greater anxiety, as neuropathic pain fully drives anxiety
symptoms. A large-scale study by Attal et al.1was consistent with
this view, as anxiety scores46 increased successively and
significantly from pain-free subjects to subjects with non-
neuropathic pain, to subjects with neuropathic pain, who
exhibited near-maximal scores. Interestingly, depression was
less strongly impacted by pain, suggesting that neuropathic pain
symptoms are so unpleasantly salient that they overwhelm other
stressors and link predominantly to anxiety within the central
nervous system. Our data may therefore be instructive when
dealing with neuropathic pain patients with anxiety, suggesting
that successfully treating ongoing pain is likely to be the key
determinant to removing patients’ ongoing anxiety.
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